Trials of sickle cell anemia treatments underway

06/17/2013 | San Diego Union-Tribune

Recruitment has begun for a midstage clinical trial to find out whether heart disease drug Lexiscan can alleviate attacks of sickle cell anemia. The NIH-supported study will test whether the drug can relieve pain and inflammation. Meanwhile, HemaQuest has completed the recruitment of patients with sickle cell disease for a Phase IIb study involving HQK-1001, which promotes the production of fetal hemoglobin.

View Full Article in:

San Diego Union-Tribune

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD